Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Phase 3 Multicenter Comparative Study to Confirm Safety and Effectiveness of the F(ab)2 Antivenom Anavip.

ClinicalTrials.gov ID: NCT00636116

Public ClinicalTrials.gov record NCT00636116. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Comparison of Anavip® and CroFab® in the Treatment of Patients With Crotalinae Envenomation: A Randomized, Prospective, Blinded, Controlled, Comparative, Multicenter Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to establish if F(ab)2 antivenom (Anavip) is safe for crotalinae envenomation. Confirm its effectiveness in preventing the occurrence of delayed coagulopathies and compare the safety and efficacy with Fab antivenom (CroFab) in patients with Crotalinae envenomation.

Study identification

NCT ID
NCT00636116
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Instituto Bioclon S.A. de C.V.
Industry
Enrollment
121 participants

Conditions and interventions

Eligibility (public fields only)

Age range
2 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2008 (Type not available)
Primary completion
Nov 2011 (Actual)
Completion
Jan 2012 (Actual)
Last update posted
Jan 10, 2012

2008 – 2012

United States locations

U.S. sites
18
U.S. states
8
U.S. cities
13
Facility City State ZIP Site status
Banner Good Samaritan Medical Center Phoenix Arizona 85006 —
Maricopa Integrated Health System Phoenix Arizona 85008 —
Northwest Medical Center Phoenix Arizona 85741 —
Tucson Medical Center Tucson Arizona 85712 —
University Physicians Hospital Tucson Arizona 85713 —
University Medical Center Tucson Arizona 85721 —
Loma Linda University Medical Center Loma Linda California 92354 —
University of California San Diego San Diego California 92103 —
Rady Children's Hospital San Diego California 92123 —
Florida Poison Information Center Jacksonsville Florida 32209 —
Sarasota Memorial Hospital Sarasota Florida 34239 —
LSU Health Sciences Center, Lousiana Poison Control Center Shreveport Louisiana 71103 —
The Children's Mercy Hospital Kansas City Missouri 64108 —
The University of New Mexico Hospital Albuquerque New Mexico 87106 —
Pitt County Memorial Hospital Greenville North Carolina 27834 —
St. Joseph Regional Health Center Bryan Texas 77802 —
West Texas Regional Poison Center at Thomason Hospital El Paso Texas 79905 —
Scott and White Memorial Hospital Temple Texas 76508 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00636116, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 10, 2012 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00636116 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →